APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Excipients

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharma Excipients Market Analysis and Forecast 2026-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchPharma Excipients Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Excipients Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Pharma Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Excipients Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Excipients Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharma Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharma Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharma Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharma Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharma Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pharma Excipients include J.M. Huber Corporation, Evonik, Eastman Chemical Company, DOW Chemical Company, Cargill, BASF, Archer Daniels Midland (ADM), AkzoNobel and ABITEC Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pharma Excipients, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharma Excipients, also provides the sales of main regions and countries. Of the upcoming market potential for Pharma Excipients, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharma Excipients sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharma Excipients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pharma Excipients sales, projected growth trends, production technology, application and end-user industry.

Pharma Excipients Segment by Company

J.M. Huber Corporation

Evonik

Eastman Chemical Company

DOW Chemical Company

Cargill

BASF

Archer Daniels Midland (ADM)

AkzoNobel

ABITEC Corporation

Pharma Excipients Segment by Type

Alcohols

Polymers

Minerals

Sugar

Others

Pharma Excipients Segment by Application

Oral Solid Dosage Forms (OSDF)

Others

Pharma Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pharma Excipients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pharma Excipients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Excipients sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharma Excipients Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Alcohols Major Manufacturers Table 3. Polymers Major Manufacturers Table 4. Minerals Major Manufacturers Table 5. Sugar Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Pharma Excipients Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Oral Solid Dosage Forms (OSDF) Major Manufacturers Table 9. Others Major Manufacturers Table 10. Pharma Excipients Industry Trends Table 11. Pharma Excipients Industry Drivers Table 12. Pharma Excipients Industry Opportunities and Challenges Table 13. Pharma Excipients Industry Restraints Table 14. Global Pharma Excipients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Pharma Excipients Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Pharma Excipients Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Pharma Excipients Revenue Market Share by Region (2021-2026) Table 18. Global Pharma Excipients Revenue Market Share by Region (2027-2032) Table 19. Global Pharma Excipients Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Pharma Excipients Sales by Region (2021-2026) & (W Tons) Table 21. Global Pharma Excipients Sales by Region (2027-2032) & (W Tons) Table 22. Global Pharma Excipients Sales Market Share by Region (2021-2026) Table 23. Global Pharma Excipients Sales Market Share by Region (2027-2032) Table 24. Global Pharma Excipients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pharma Excipients Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Pharma Excipients Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Pharma Excipients Sales Market Share by Manufacturers (2021-2026) Table 28. Global Pharma Excipients Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 29. Global Pharma Excipients Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Pharma Excipients Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Pharma Excipients Manufacturers, Product Type & Application Table 32. Global Pharma Excipients Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Pharma Excipients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Pharma Excipients Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pharma Excipients Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Pharma Excipients Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Pharma Excipients Revenue Market Share by Type (2021-2026) Table 39. Global Pharma Excipients Revenue Market Share by Type (2027-2032) Table 40. Global Pharma Excipients Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 41. Global Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 42. Global Pharma Excipients Sales by Type (2027-2032) & (W Tons) Table 43. Global Pharma Excipients Sales Market Share by Type (2021-2026) Table 44. Global Pharma Excipients Sales Market Share by Type (2027-2032) Table 45. Global Pharma Excipients Price by Type (2021-2026) & (US$/Ton) Table 46. Global Pharma Excipients Price by Type (2027-2032) & (US$/Ton) Table 47. Global Pharma Excipients Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pharma Excipients Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Pharma Excipients Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Pharma Excipients Revenue Market Share by Application (2021-2026) Table 51. Global Pharma Excipients Revenue Market Share by Application (2027-2032) Table 52. Global Pharma Excipients Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 53. Global Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 54. Global Pharma Excipients Sales by Application (2027-2032) & (W Tons) Table 55. Global Pharma Excipients Sales Market Share by Application (2021-2026) Table 56. Global Pharma Excipients Sales Market Share by Application (2027-2032) Table 57. Global Pharma Excipients Price by Application (2021-2026) & (US$/Ton) Table 58. Global Pharma Excipients Price by Application (2027-2032) & (US$/Ton) Table 59. J.M. Huber Corporation Company Information Table 60. J.M. Huber Corporation Business Overview Table 61. J.M. Huber Corporation Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 62. J.M. Huber Corporation Pharma Excipients Product Portfolio Table 63. J.M. Huber Corporation Recent Development Table 64. Evonik Company Information Table 65. Evonik Business Overview Table 66. Evonik Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Evonik Pharma Excipients Product Portfolio Table 68. Evonik Recent Development Table 69. Eastman Chemical Company Company Information Table 70. Eastman Chemical Company Business Overview Table 71. Eastman Chemical Company Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Eastman Chemical Company Pharma Excipients Product Portfolio Table 73. Eastman Chemical Company Recent Development Table 74. DOW Chemical Company Company Information Table 75. DOW Chemical Company Business Overview Table 76. DOW Chemical Company Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. DOW Chemical Company Pharma Excipients Product Portfolio Table 78. DOW Chemical Company Recent Development Table 79. Cargill Company Information Table 80. Cargill Business Overview Table 81. Cargill Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Cargill Pharma Excipients Product Portfolio Table 83. Cargill Recent Development Table 84. BASF Company Information Table 85. BASF Business Overview Table 86. BASF Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. BASF Pharma Excipients Product Portfolio Table 88. BASF Recent Development Table 89. Archer Daniels Midland (ADM) Company Information Table 90. Archer Daniels Midland (ADM) Business Overview Table 91. Archer Daniels Midland (ADM) Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio Table 93. Archer Daniels Midland (ADM) Recent Development Table 94. AkzoNobel Company Information Table 95. AkzoNobel Business Overview Table 96. AkzoNobel Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. AkzoNobel Pharma Excipients Product Portfolio Table 98. AkzoNobel Recent Development Table 99. ABITEC Corporation Company Information Table 100. ABITEC Corporation Business Overview Table 101. ABITEC Corporation Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. ABITEC Corporation Pharma Excipients Product Portfolio Table 103. ABITEC Corporation Recent Development Table 104. North America Pharma Excipients Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Pharma Excipients Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 107. North America Pharma Excipients Sales by Type (2027-2032) & (W Tons) Table 108. North America Pharma Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 109. North America Pharma Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 110. North America Pharma Excipients Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Pharma Excipients Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 113. North America Pharma Excipients Sales by Application (2027-2032) & (W Tons) Table 114. North America Pharma Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 115. North America Pharma Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 116. North America Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Pharma Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Pharma Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Pharma Excipients Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 120. North America Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 121. North America Pharma Excipients Sales by Country (2027-2032) & (W Tons) Table 122. North America Pharma Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 123. North America Pharma Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 124. United States Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 125. Canada Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 126. Europe Pharma Excipients Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Pharma Excipients Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 129. Europe Pharma Excipients Sales by Type (2027-2032) & (W Tons) Table 130. Europe Pharma Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 131. Europe Pharma Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 132. Europe Pharma Excipients Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Pharma Excipients Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 135. Europe Pharma Excipients Sales by Application (2027-2032) & (W Tons) Table 136. Europe Pharma Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 137. Europe Pharma Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 138. Europe Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Pharma Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Pharma Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Pharma Excipients Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 142. Europe Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 143. Europe Pharma Excipients Sales by Country (2027-2032) & (W Tons) Table 144. Europe Pharma Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 145. Europe Pharma Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 146. Germany Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 147. France Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 148. U.K. Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 149. Italy Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 151. Nordic Countries Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 152. China Pharma Excipients Revenue by Type (2021-2026) & (US$ Million) Table 153. China Pharma Excipients Revenue by Type (2027-2032) & (US$ Million) Table 154. China Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 155. China Pharma Excipients Sales by Type (2027-2032) & (W Tons) Table 156. China Pharma Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 157. China Pharma Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 158. China Pharma Excipients Revenue by Application (2021-2026) & (US$ Million) Table 159. China Pharma Excipients Revenue by Application (2027-2032) & (US$ Million) Table 160. China Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 161. China Pharma Excipients Sales by Application (2027-2032) & (W Tons) Table 162. China Pharma Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 163. China Pharma Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 164. Asia Pharma Excipients Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Pharma Excipients Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 167. Asia Pharma Excipients Sales by Type (2027-2032) & (W Tons) Table 168. Asia Pharma Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 169. Asia Pharma Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 170. Asia Pharma Excipients Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Pharma Excipients Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 173. Asia Pharma Excipients Sales by Application (2027-2032) & (W Tons) Table 174. Asia Pharma Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 175. Asia Pharma Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 176. Asia Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Pharma Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Pharma Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Pharma Excipients Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 180. Asia Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 181. Asia Pharma Excipients Sales by Country (2027-2032) & (W Tons) Table 182. Asia Pharma Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 183. Asia Pharma Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 184. Japan Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 185. South Korea Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 186. India Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 187. Australia Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 188. China Taiwan Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Pharma Excipients Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Pharma Excipients Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 193. SAMEA Pharma Excipients Sales by Type (2027-2032) & (W Tons) Table 194. SAMEA Pharma Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 195. SAMEA Pharma Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 196. SAMEA Pharma Excipients Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Pharma Excipients Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 199. SAMEA Pharma Excipients Sales by Application (2027-2032) & (W Tons) Table 200. SAMEA Pharma Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 201. SAMEA Pharma Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 202. SAMEA Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Pharma Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Pharma Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Pharma Excipients Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 206. SAMEA Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 207. SAMEA Pharma Excipients Sales by Country (2027-2032) & (W Tons) Table 208. SAMEA Pharma Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 209. SAMEA Pharma Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 210. Brazil Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 211. Argentina Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 212. Chile Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 213. Colombia Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 214. Peru Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 216. Israel Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 217. UAE Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 218. Turkey Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 219. Iran Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 220. Egypt Pharma Excipients Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Pharma Excipients Distributors List Table 224. Pharma Excipients Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Pharma Excipients Image Figure 2. Global Pharma Excipients Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Excipients Market Size Share 2021 VS 2025 VS 2032 Figure 4. Alcohols Image Figure 5. Polymers Image Figure 6. Minerals Image Figure 7. Sugar Image Figure 8. Others Image Figure 9. Global Pharma Excipients Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Pharma Excipients Market Size Share 2021 VS 2025 VS 2032 Figure 11. Oral Solid Dosage Forms (OSDF) Image Figure 12. Others Image Figure 13. Global Pharma Excipients Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharma Excipients Revenue (2021-2032) & (US$ Million) Figure 15. Global Pharma Excipients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Pharma Excipients Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Pharma Excipients Revenue Market Share by Region (2021-2032) Figure 18. Global Pharma Excipients Sales (2021-2032) & (W Tons) Figure 19. Global Pharma Excipients Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 20. Global Pharma Excipients Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Pharma Excipients Sales YoY (2021-2032) & (W Tons) Figure 22. Europe Pharma Excipients Sales YoY (2021-2032) & (W Tons) Figure 23. China Pharma Excipients Sales YoY (2021-2032) & (W Tons) Figure 24. Asia (Excluding China) Pharma Excipients Sales YoY (2021-2032) & (W Tons) Figure 25. South America, Middle East and Africa Pharma Excipients Sales YoY (2021-2032) & (W Tons) Figure 26. Global Pharma Excipients Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Pharma Excipients Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Pharma Excipients Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Pharma Excipients Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Pharma Excipients Revenue Market Share by Type (2021-2032) Figure 32. Global Pharma Excipients Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 33. Global Pharma Excipients Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Pharma Excipients Sales Market Share by Type (2021-2032) Figure 35. Global Pharma Excipients Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Pharma Excipients Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Pharma Excipients Revenue Market Share by Application (2021-2032) Figure 38. Global Pharma Excipients Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 39. Global Pharma Excipients Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Pharma Excipients Sales Market Share by Application (2021-2032) Figure 41. North America Pharma Excipients Revenue Share by Type (2021-2032) Figure 42. North America Pharma Excipients Sales Share by Type (2021-2032) Figure 43. North America Pharma Excipients Revenue Share by Application (2021-2032) Figure 44. North America Pharma Excipients Sales Share by Application (2021-2032) Figure 45. North America Pharma Excipients Revenue Share by Country (2021-2032) Figure 46. North America Pharma Excipients Sales Share by Country (2021-2032) Figure 47. Europe Pharma Excipients Revenue Share by Type (2021-2032) Figure 48. Europe Pharma Excipients Sales Share by Type (2021-2032) Figure 49. Europe Pharma Excipients Revenue Share by Application (2021-2032) Figure 50. Europe Pharma Excipients Sales Share by Application (2021-2032) Figure 51. Europe Pharma Excipients Revenue Share by Country (2021-2032) Figure 52. Europe Pharma Excipients Sales Share by Country (2021-2032) Figure 53. China Pharma Excipients Revenue Share by Type (2021-2032) Figure 54. China Pharma Excipients Sales Share by Type (2021-2032) Figure 55. China Pharma Excipients Revenue Share by Application (2021-2032) Figure 56. China Pharma Excipients Sales Share by Application (2021-2032) Figure 57. Asia Pharma Excipients Revenue Share by Type (2021-2032) Figure 58. Asia Pharma Excipients Sales Share by Type (2021-2032) Figure 59. Asia Pharma Excipients Revenue Share by Application (2021-2032) Figure 60. Asia Pharma Excipients Sales Share by Application (2021-2032) Figure 61. Asia Pharma Excipients Revenue Share by Country (2021-2032) Figure 62. Asia Pharma Excipients Sales Share by Country (2021-2032) Figure 63. SAMEA Pharma Excipients Revenue Share by Type (2021-2032) Figure 64. SAMEA Pharma Excipients Sales Share by Type (2021-2032) Figure 65. SAMEA Pharma Excipients Revenue Share by Application (2021-2032) Figure 66. SAMEA Pharma Excipients Sales Share by Application (2021-2032) Figure 67. SAMEA Pharma Excipients Revenue Share by Country (2021-2032) Figure 68. SAMEA Pharma Excipients Sales Share by Country (2021-2032) Figure 69. Pharma Excipients Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Pharma Excipients Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Alcohols
  • Polymers
  • Minerals
  • Sugar
  • Others
Applications
  • Oral Solid Dosage Forms (OSDF)
  • Others
Companies covered
  • J.M. Huber Corporation
  • Evonik
  • Eastman Chemical Company
  • DOW Chemical Company
  • Cargill
  • BASF
  • Archer Daniels Midland (ADM)
  • AkzoNobel
  • ABITEC Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharma Excipients Market by Type
  3. 1.2.1 Global Pharma Excipients Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Alcohols
  5. 1.2.3 Polymers
  6. 1.2.4 Minerals
  7. 1.2.5 Sugar
  8. 1.2.6 Others
  9. 1.3 Pharma Excipients Market by Application
  10. 1.3.1 Global Pharma Excipients Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Oral Solid Dosage Forms (OSDF)
  12. 1.3.3 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pharma Excipients Market Dynamics
  1. 2.1 Pharma Excipients Industry Trends
  2. 2.2 Pharma Excipients Industry Drivers
  3. 2.3 Pharma Excipients Industry Opportunities and Challenges
  4. 2.4 Pharma Excipients Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pharma Excipients Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pharma Excipients Revenue by Region
  3. 3.2.1 Global Pharma Excipients Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharma Excipients Revenue by Region (2021-2026)
  5. 3.2.3 Global Pharma Excipients Revenue by Region (2027-2032)
  6. 3.2.4 Global Pharma Excipients Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pharma Excipients Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pharma Excipients Sales by Region
  9. 3.4.1 Global Pharma Excipients Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pharma Excipients Sales by Region (2021-2026)
  11. 3.4.3 Global Pharma Excipients Sales by Region (2027-2032)
  12. 3.4.4 Global Pharma Excipients Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pharma Excipients Revenue by Manufacturers
  2. 4.1.1 Global Pharma Excipients Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pharma Excipients Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pharma Excipients Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharma Excipients Sales by Manufacturers
  6. 4.2.1 Global Pharma Excipients Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pharma Excipients Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pharma Excipients Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pharma Excipients Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pharma Excipients Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pharma Excipients Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pharma Excipients Manufacturers, Product Type & Application
  13. 4.7 Global Pharma Excipients Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pharma Excipients Market CR5 and HHI
  16. 4.8.2 2025 Pharma Excipients Tier 1, Tier 2, and Tier 3
5 Pharma Excipients Market by Type
  1. 5.1 Global Pharma Excipients Revenue by Type
  2. 5.1.1 Global Pharma Excipients Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pharma Excipients Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pharma Excipients Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pharma Excipients Sales by Type
  6. 5.2.1 Global Pharma Excipients Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharma Excipients Sales by Type (2021-2032) & (W Tons)
  8. 5.2.3 Global Pharma Excipients Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pharma Excipients Price by Type
6 Pharma Excipients Market by Application
  1. 6.1 Global Pharma Excipients Revenue by Application
  2. 6.1.1 Global Pharma Excipients Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pharma Excipients Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pharma Excipients Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pharma Excipients Sales by Application
  6. 6.2.1 Global Pharma Excipients Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pharma Excipients Sales by Application (2021-2032) & (W Tons)
  8. 6.2.3 Global Pharma Excipients Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pharma Excipients Price by Application
7 Company Profiles
  1. 7.1 J.M. Huber Corporation
  2. 7.1.1 J.M. Huber Corporation Company Information
  3. 7.1.2 J.M. Huber Corporation Business Overview
  4. 7.1.3 J.M. Huber Corporation Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 J.M. Huber Corporation Pharma Excipients Product Portfolio
  6. 7.1.5 J.M. Huber Corporation Recent Developments
  7. 7.2 Evonik
  8. 7.2.1 Evonik Company Information
  9. 7.2.2 Evonik Business Overview
  10. 7.2.3 Evonik Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Evonik Pharma Excipients Product Portfolio
  12. 7.2.5 Evonik Recent Developments
  13. 7.3 Eastman Chemical Company
  14. 7.3.1 Eastman Chemical Company Company Information
  15. 7.3.2 Eastman Chemical Company Business Overview
  16. 7.3.3 Eastman Chemical Company Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eastman Chemical Company Pharma Excipients Product Portfolio
  18. 7.3.5 Eastman Chemical Company Recent Developments
  19. 7.4 DOW Chemical Company
  20. 7.4.1 DOW Chemical Company Company Information
  21. 7.4.2 DOW Chemical Company Business Overview
  22. 7.4.3 DOW Chemical Company Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 DOW Chemical Company Pharma Excipients Product Portfolio
  24. 7.4.5 DOW Chemical Company Recent Developments
  25. 7.5 Cargill
  26. 7.5.1 Cargill Company Information
  27. 7.5.2 Cargill Business Overview
  28. 7.5.3 Cargill Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cargill Pharma Excipients Product Portfolio
  30. 7.5.5 Cargill Recent Developments
  31. 7.6 BASF
  32. 7.6.1 BASF Company Information
  33. 7.6.2 BASF Business Overview
  34. 7.6.3 BASF Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 BASF Pharma Excipients Product Portfolio
  36. 7.6.5 BASF Recent Developments
  37. 7.7 Archer Daniels Midland (ADM)
  38. 7.7.1 Archer Daniels Midland (ADM) Company Information
  39. 7.7.2 Archer Daniels Midland (ADM) Business Overview
  40. 7.7.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio
  42. 7.7.5 Archer Daniels Midland (ADM) Recent Developments
  43. 7.8 AkzoNobel
  44. 7.8.1 AkzoNobel Company Information
  45. 7.8.2 AkzoNobel Business Overview
  46. 7.8.3 AkzoNobel Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 AkzoNobel Pharma Excipients Product Portfolio
  48. 7.8.5 AkzoNobel Recent Developments
  49. 7.9 ABITEC Corporation
  50. 7.9.1 ABITEC Corporation Company Information
  51. 7.9.2 ABITEC Corporation Business Overview
  52. 7.9.3 ABITEC Corporation Pharma Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ABITEC Corporation Pharma Excipients Product Portfolio
  54. 7.9.5 ABITEC Corporation Recent Developments
8 North America
  1. 8.1 North America Pharma Excipients Market Size by Type
  2. 8.1.1 North America Pharma Excipients Revenue by Type (2021-2032)
  3. 8.1.2 North America Pharma Excipients Sales by Type (2021-2032)
  4. 8.1.3 North America Pharma Excipients Price by Type (2021-2032)
  5. 8.2 North America Pharma Excipients Market Size by Application
  6. 8.2.1 North America Pharma Excipients Revenue by Application (2021-2032)
  7. 8.2.2 North America Pharma Excipients Sales by Application (2021-2032)
  8. 8.2.3 North America Pharma Excipients Price by Application (2021-2032)
  9. 8.3 North America Pharma Excipients Market Size by Country
  10. 8.3.1 North America Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pharma Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pharma Excipients Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pharma Excipients Market Size by Type
  2. 9.1.1 Europe Pharma Excipients Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pharma Excipients Sales by Type (2021-2032)
  4. 9.1.3 Europe Pharma Excipients Price by Type (2021-2032)
  5. 9.2 Europe Pharma Excipients Market Size by Application
  6. 9.2.1 Europe Pharma Excipients Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pharma Excipients Sales by Application (2021-2032)
  8. 9.2.3 Europe Pharma Excipients Price by Application (2021-2032)
  9. 9.3 Europe Pharma Excipients Market Size by Country
  10. 9.3.1 Europe Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pharma Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pharma Excipients Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Pharma Excipients Market Size by Type
  2. 10.1.1 China Pharma Excipients Revenue by Type (2021-2032)
  3. 10.1.2 China Pharma Excipients Sales by Type (2021-2032)
  4. 10.1.3 China Pharma Excipients Price by Type (2021-2032)
  5. 10.2 China Pharma Excipients Market Size by Application
  6. 10.2.1 China Pharma Excipients Revenue by Application (2021-2032)
  7. 10.2.2 China Pharma Excipients Sales by Application (2021-2032)
  8. 10.2.3 China Pharma Excipients Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharma Excipients Market Size by Type
  2. 11.1.1 Asia Pharma Excipients Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pharma Excipients Sales by Type (2021-2032)
  4. 11.1.3 Asia Pharma Excipients Price by Type (2021-2032)
  5. 11.2 Asia Pharma Excipients Market Size by Application
  6. 11.2.1 Asia Pharma Excipients Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pharma Excipients Sales by Application (2021-2032)
  8. 11.2.3 Asia Pharma Excipients Price by Application (2021-2032)
  9. 11.3 Asia Pharma Excipients Market Size by Country
  10. 11.3.1 Asia Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pharma Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pharma Excipients Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharma Excipients Market Size by Type
  2. 12.1.1 SAMEA Pharma Excipients Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pharma Excipients Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pharma Excipients Price by Type (2021-2032)
  5. 12.2 SAMEA Pharma Excipients Market Size by Application
  6. 12.2.1 SAMEA Pharma Excipients Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pharma Excipients Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pharma Excipients Price by Application (2021-2032)
  9. 12.3 SAMEA Pharma Excipients Market Size by Country
  10. 12.3.1 SAMEA Pharma Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pharma Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pharma Excipients Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pharma Excipients Value Chain Analysis
  2. 13.1.1 Pharma Excipients Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pharma Excipients Production Mode & Process
  6. 13.2 Pharma Excipients Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pharma Excipients Distributors
  9. 13.2.3 Pharma Excipients Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst